Corventis’ Nuvant cardiac monitor cleared for US marketing

Categories: Latest News.

Corventis received final FDA 510(k) clearance for its Nuvant mobile cardiac telemetry system.  Part of the system, the PiiX peel-and-stick sensor, got a fair amount of attention at CES.  It also was the first startup via the West Wireless Health Institute.  Even more important, Corventis now has the approval from the Centers for Medicaid and Medicare (CMS) for its monitoring facility, which means they are now able to bill for services provided to patients with Medicare.  As Brian Dolan on Mobihealthnews points out, their billing is under the same code as CardioNet’s system, which wound up in financial difficulty after a 33% cut in reimbursement rates.  The Mobihealthnews article is far more readable than the press release.